Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

InMed Pharmaceuticals Inc C.CAN

Sector: Healthcare | Sub-Sector: Biotechnology
Primary Symbol: C.IN
Alternate Symbol(s):  IMLFF

InMed Pharmaceuticals Inc formerly, Cannabis Technologies Inc, is a biopharmaceutical company that engages developing cannabis-based botanical and non-botanical therapies through the research and development into the pharmacology of cannabinoids.
Price: $0.22 | Change: $0.00 | %Change: 0.00%
Volume: 0 | Day High/Low: N/A/N/A | 52 Week High/Low: 0.71/0.185

Snapshot

Last Traded: October 23, 2014 10:25 Transaction Volume: 0
Open: $0.22 Previous Close: $0.22
Bid: $0.215 Ask: $0.22
Bid Size: 5,000 Ask Size: 5,000
Market Cap: $9.0m Shares Out: 40.8m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest Bullboard Posts

  • RE:RE:UBC Success Stories

    0 stars

    My apologies, for some reason I've had issues whenever I cut and paste on here. Here's a list of several success stories. >>>1993 UBC...

    2.5 stars


  • RE:UBC Success Stories

    0 stars

    http://us4.campaign-archive2.com/?u=80114a1e95fa5bb145c563ab6&id=97d0ddadcf&e=76fb1d0afe

    2.5 stars


  • UBC Success Stories

    0 stars

    Here's a list of Success Stories that have come out of UBC over the years. Here's a History Of Success Stories that have come out of UBC...

    2.5 stars


  • RE:Great News

    0 stars

    That is some great news. Looks like InMed is using the same model as GWPH. A strategic collaboration with one of the top universities in...

    2.5 stars


  • RE:Great News

    0 stars

    Great news but not exactly the best timing coming when the only thing on people's minds is domestic terrorism.  Still a very important...

    2 stars